Efficacy and safety of 0.05% micellar nano-particulate (MNP) cyclosporine ophthalmic emulsion in the treatment of moderate-to-severe keratoconjunctivitis sicca: a 12-week, multicenter, randomized, active-controlled trial

BACKGROUND: Keratoconjunctivitis sicca or dry eye disease (DED) is a multifactorial disorder underpinned by a complex inflammatory cycle. Introduction of topical cyclosporine has been a significant advance in the management of DED. In recent years advancements in formulation technology have led to d...

Descripción completa

Detalles Bibliográficos
Autores principales: Rao, A Tarakeswara, Gupta, Amit, Chauhan, Tulika, Basu, Sayan, Batra, Nitin, Sharma, Namrata, Sangwan, Virender S, Gupta, Vinay, Mukherjee, Shoibal
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10041473/
https://www.ncbi.nlm.nih.gov/pubmed/36973703
http://dx.doi.org/10.1186/s12886-023-02838-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10041473/
https://www.ncbi.nlm.nih.gov/pubmed/36973703
http://dx.doi.org/10.1186/s12886-023-02838-z

Ejemplares similares